Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 14Rectal Neoplasms 10Colonic Neoplasms 6Stomach Neoplasms 3Unspecified Adult Solid Tumor, Protocol Specific 2Mesothelioma, Malignant 2Thrombocytopenia 1Squamous Cell Carcinoma of Head and Neck 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Liver, Cancer of, Primary Resectable 1Inoperable Esophageal Cancer Stage I-III 1Hepatocellular Carcinoma Resectable 1Hepatecellular Carcinoma 1Head and Neck Squamous Cell Cancer 1Fruquintinib 1Esophageal Squamous Cell Carcinoma 1Colorectal Cancer Metastatic 1Colon Cancer Liver Metastasis 1Carcinoma, Hepatocellular 1Advanced Metastatic Colorectal Cancer 1Advanced Gastric Cancer 1Advanced Colorectal Carcinoma 1Advanced Colorectal Cancer 1

Interventions

Paclitaxel 9apatinib 8Capecitabine 7Oxaliplatin 6Cisplatin 5camrelizumab 4S 1 (combination) 4Fluorouracil 3Docetaxel 3130-nm albumin-bound paclitaxel 3titanium silicide 2Leucovorin 2vorolanib 1trifluridine tipiracil drug combination 1tipiracil 1spartalizumab 1rucaparib 1relatlimab 1raltitrexed 1pazopanib 1olaparib 1lobaplatin 1linrodostat 1endostar protein 1durvalumab 1dacomitinib 1capivasertib 1Trifluridine 1Sunitinib 1SHR-1701 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Advanced Gastric Cancer × raltitrexed × Clear all
NCT02072317 2014-02-26

Paclitaxel Plus Raltitrexed Plug Compare With Taxol Second-line Treatment for Advanced Gastric Cancer

Fudan University

Phase 2 Unknown
140 enrolled
Gastrointestinal

Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡